Ferenc Tracik
Chief Tech/Sci/R&D Officer at NEUROSENSE THERAPEUTICS LTD.
Net worth: 223 771 $ as of 2024-03-30
Profile
Ferenc Tracik's career history includes current and former positions as well as education.
Currently, he is the Chief Medical Officer at Neurosense Therapeutics Ltd.
Previously, he held the position of Managing Director-Germany Specialty Medicines at Teva Pharmaceutical Industries Ltd.
from 2013 to 2017.
From 2017 to 2020, he served as the VP-Medical Europe & Canada at Biogen, Inc. Additionally, he has worked as the Global Head-Medical at Orphazyme A.
In terms of education, Dr. Tracik holds doctorate degrees from Freie Universität Berlin and the University of Regensburg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 122,951 ( 0.90% ) | 223 771 $ | 2024-03-30 |
Ferenc Tracik active positions
| Companies | Position | Start |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 2021-11-30 |
Former positions of Ferenc Tracik
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2020-10-31 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2017-03-31 |
| ORPHAZYME A/S | Corporate Officer/Principal | - |
Training of Ferenc Tracik
| University of Regensburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| Private companies | 1 |
|---|---|
| Neurosense Therapeutics Ltd. |
- Stock Market
- Insiders
- Ferenc Tracik